Jim D Durbin (Jim Durbin)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Structural Basis

Human Serum Albumin

Top Venues

ACS chemical biology

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Haitao Hu, Anthony S Ransdell, Hongchang Qu, Jim D Durbin, Francisco A Valenzuela, Selene Hernandez-Buquer, Malgorzata D Gonciarz
Probing the Binding Mechanism of Acylated Peptides to Human Serum Albumin. ACS chemical biology (2023)
Haitao Hu, Anthony S Ransdell, Hongchang Qu, Jim D Durbin, Francisco A Valenzuela, Selene Hernandez-Buquer, Malgorzata D Gonciarz
Probing the Binding Mechanism of Acylated Peptides to Human Serum Albumin. ACS chemical biology 18 (5) (2023)
Haitao Hu, Anthony S Ransdell, Hongchang Qu, Jim D Durbin, Francisco A Valenzuela, Selene Hernandez-Buquer, Malgorzata D Gonciarz
Probing the Binding Mechanism of Acylated Peptides to Human Serum Albumin. ACS chemical biology 18 (5) (2023)
Timothy B Durham, Junliang Hao, Patrick Spinazze, Douglas R Stack, James L Toth, Steven Massey, Curren T Mbofana, Richard D Johnston, Jayana P Lineswala, Aaron Wrobleski, Jose Miguel Mínguez, Carlos Perez, Daryl L Smith, Jason Lamar, Rebecca Leon, Christopher Corkins, Jim D Durbin, Frances Tung, Sherry Guo, Ryan J Linder, Nathan Yumibe, Wei Wang, James MacKrell, Meghan Antonellis, Bethany Mascaro
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor. Journal of medicinal chemistry (2023)
Haitao Hu, Anthony S Ransdell, Hongchang Qu, Jim D Durbin, Francisco A Valenzuela, Selene Hernandez-Buquer, Malgorzata D Gonciarz
Probing the Binding Mechanism of Acylated Peptides to Human Serum Albumin. ACS chemical biology 18 (5) (2023)
Jeffrey S Boyles, Catherine B Beidler, Beth A Strifler, Daniel S Girard, Zhanna Druzina, Jim D Durbin, Michelle L Swearingen, Linda N Lee, Kristine Kikly, Sudhakar Chintharlapalli, Derrick R Witcher
Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody. mAbs 12 (1) (2021)